Gene networks and systems biology in Alzheimer's disease: Insights from multi-omics approaches.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE
    • Publication Information:
      Publication: 2020- : Hoboken, NJ : John Wiley & Sons, Ltd.
      Original Publication: Orlando, FL : Elsevier, Inc.
    • Subject Terms:
    • Abstract:
      Despite numerous studies in the field of dementia and Alzheimer's disease (AD), a comprehensive understanding of this devastating disease remains elusive. Bulk transcriptomics have provided insights into the underlying genetic factors at a high level. Subsequent technological advancements have focused on single-cell omics, encompassing techniques such as single-cell RNA sequencing and epigenomics, enabling the capture of RNA transcripts and chromatin states at a single cell or nucleus resolution. Furthermore, the emergence of spatial omics has allowed the study of gene responses in the vicinity of amyloid beta plaques or across various brain regions. With the vast amount of data generated, utilizing gene regulatory networks to comprehensively study this disease has become essential. This review delves into some techniques employed in the field of AD, explores the discoveries made using these techniques, and provides insights into the future of the field.
      (© 2024 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)
    • References:
      Nat Methods. 2023 Sep;20(9):1355-1367. (PMID: 37443338)
      Nat Rev Genet. 2023 Nov;24(11):739-754. (PMID: 37365273)
      Nat Methods. 2024 Feb 26;:. (PMID: 38409223)
      Nat Methods. 2022 Jan;19(1):41-50. (PMID: 34949812)
      Elife. 2019 Jul 08;8:. (PMID: 31282856)
      Neurol Clin. 2017 May;35(2):263-281. (PMID: 28410659)
      Nat Methods. 2021 Oct;18(10):1196-1203. (PMID: 34608324)
      PLoS Genet. 2014 Oct 30;10(10):e1004722. (PMID: 25357204)
      Nat Neurosci. 2021 Feb;24(2):276-287. (PMID: 33432193)
      Cell. 2017 Jun 15;169(7):1276-1290.e17. (PMID: 28602351)
      Cell Rep Methods. 2023 Jun 12;3(6):100498. (PMID: 37426759)
      Cell Genom. 2023 Feb 02;3(3):100263. (PMID: 36950385)
      J Clin Med. 2019 Aug 16;8(8):. (PMID: 31426376)
      Sci Data. 2023 Jan 24;10(1):51. (PMID: 36693875)
      Nat Med. 2020 Jan;26(1):131-142. (PMID: 31932797)
      BMC Bioinformatics. 2007 Jan 24;8:22. (PMID: 17250769)
      Front Neurosci. 2021 Aug 19;15:688090. (PMID: 34489623)
      Nat Biotechnol. 2021 Oct;39(10):1202-1215. (PMID: 33941931)
      Alzheimers Dement (N Y). 2018 Sep 06;4:575-590. (PMID: 30406177)
      Neurobiol Dis. 2021 Dec;160:105530. (PMID: 34634459)
      Continuum (Minneap Minn). 2019 Feb;25(1):34-51. (PMID: 30707186)
      Nat Methods. 2016 Nov;13(11):919-922. (PMID: 27643841)
      Genome Biol. 2014;15(12):550. (PMID: 25516281)
      Bioinformatics. 2011 Jun 15;27(12):1739-40. (PMID: 21546393)
      Nature. 2019 Jun;570(7761):332-337. (PMID: 31042697)
      BMC Med Genomics. 2019 Sep 9;12(1):128. (PMID: 31500627)
      Nat Neurosci. 2018 Jun;21(6):811-819. (PMID: 29802388)
      Signal Transduct Target Ther. 2023 Jun 30;8(1):248. (PMID: 37386015)
      Genome Biol. 2018 Feb 6;19(1):15. (PMID: 29409532)
      Cell. 2020 Aug 20;182(4):976-991.e19. (PMID: 32702314)
      Nat Neurosci. 2019 Dec;22(12):2087-2097. (PMID: 31768052)
      Dialogues Clin Neurosci. 2003 Mar;5(1):101-8. (PMID: 22034141)
      Nucleic Acids Res. 2015 Apr 20;43(7):e47. (PMID: 25605792)
      Neuron. 2022 Sep 21;110(18):2929-2948.e8. (PMID: 35882228)
      Nat Methods. 2019 Dec;16(12):1289-1296. (PMID: 31740819)
      Nat Biotechnol. 2019 Dec;37(12):1482-1492. (PMID: 31796933)
      Nat Genet. 2000 May;25(1):25-9. (PMID: 10802651)
      Gigascience. 2020 Dec 26;9(12):. (PMID: 33367645)
      Alzheimers Dement. 2022 May;18(5):875-887. (PMID: 34590423)
      BMC Syst Biol. 2007 Jun 04;1:24. (PMID: 17547772)
      Acta Neuropathol. 2020 Dec;140(6):793-810. (PMID: 32865691)
      Nat Biotechnol. 2019 Jun;37(6):685-691. (PMID: 31061482)
      Nat Protoc. 2020 Nov;15(11):3632-3662. (PMID: 33046898)
      J Cell Biol. 2018 Feb 5;217(2):459-472. (PMID: 29196460)
      Methods. 2012 Nov;58(3):268-76. (PMID: 22652625)
      Nat Commun. 2021 Feb 17;12(1):1088. (PMID: 33597522)
      Cell. 2019 Jun 13;177(7):1873-1887.e17. (PMID: 31178122)
      Nat Commun. 2023 Apr 21;14(1):2314. (PMID: 37085492)
      Nat Methods. 2022 Sep;19(9):1097-1108. (PMID: 36068320)
      Sci Adv. 2021 Jan 6;7(2):. (PMID: 33523961)
      Nat Rev Neurol. 2017 Aug;13(8):457-476. (PMID: 28708131)
      Nat Methods. 2018 Dec;15(12):1053-1058. (PMID: 30504886)
      Nat Genet. 2021 Aug;53(8):1143-1155. (PMID: 34239132)
      Nat Methods. 2023 Sep;20(9):1323-1335. (PMID: 37550580)
      Brief Bioinform. 2021 Jul 20;22(4):. (PMID: 33147626)
      N Engl J Med. 2023 Jan 5;388(1):9-21. (PMID: 36449413)
      Nat Rev Drug Discov. 2023 Jun;22(6):496-520. (PMID: 37117846)
      Nat Commun. 2021 Feb 24;12(1):1158. (PMID: 33627648)
      Nature. 2022 Mar;603(7903):885-892. (PMID: 35165441)
      Neuron. 2022 Nov 2;110(21):3458-3483. (PMID: 36327895)
      Lancet Neurol. 2021 Jan;20(1):68-80. (PMID: 33340485)
      Front Mol Neurosci. 2020 Oct 28;13:134. (PMID: 33192286)
      Bioinformatics. 2010 Jan 1;26(1):139-40. (PMID: 19910308)
      Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15307-11. (PMID: 22949636)
      Nat Rev Genet. 2023 Aug;24(8):550-572. (PMID: 37002403)
      Cell Syst. 2019 Apr 24;8(4):281-291.e9. (PMID: 30954476)
      Nat Rev Neurosci. 2019 Mar;20(3):148-160. (PMID: 30737462)
      Nat Biotechnol. 2024 Feb;42(2):293-304. (PMID: 37231261)
      Nat Neurosci. 2023 Jun;26(6):970-982. (PMID: 37264161)
      Alzheimers Res Ther. 2020 Mar 23;12(1):29. (PMID: 32293531)
      Nat Methods. 2019 Aug;16(8):715-721. (PMID: 31363220)
      Biomolecules. 2022 Jun 23;12(7):. (PMID: 35883430)
      Alzheimers Dement. 2021 Jul;17(7):1179-1188. (PMID: 33522086)
      Genome Biol. 2021 Dec 28;22(1):351. (PMID: 34963480)
      Nat Rev Neurosci. 2020 Jan;21(1):21-35. (PMID: 31780819)
      Nat Biotechnol. 2022 Oct;40(10):1458-1466. (PMID: 35501393)
      Cell Death Dis. 2022 Aug 15;13(8):706. (PMID: 35970828)
      Sci Rep. 2021 Mar 1;11(1):4865. (PMID: 33649380)
      Cell. 2016 Feb 11;164(4):603-15. (PMID: 26871627)
      J Neuropathol Exp Neurol. 2013 Jun;72(6):462-71. (PMID: 23656989)
      Int J Mol Sci. 2023 Jul 12;24(14):. (PMID: 37511104)
      Nat Genet. 2020 Nov;52(11):1158-1168. (PMID: 33106633)
      J Alzheimers Dis. 2011;24(2):235-45. (PMID: 21263195)
      J Exp Med. 2021 Sep 6;218(9):. (PMID: 34292312)
      Hum Mol Genet. 1998 Mar;7(3):533-40. (PMID: 9467014)
      Nat Commun. 2020 Nov 30;11(1):6129. (PMID: 33257666)
      Sci Rep. 2019 Mar 26;9(1):5233. (PMID: 30914743)
      Nat Neurosci. 2023 Feb;26(2):181-195. (PMID: 36593328)
      Cell Rep. 2023 Jul 25;42(7):112785. (PMID: 37436901)
      BMC Bioinformatics. 2008 Dec 29;9:559. (PMID: 19114008)
      J R Stat Soc Series B Stat Methodol. 2020 Dec;82(5):1273-1300. (PMID: 37220626)
      Alzheimers Res Ther. 2019 Aug 9;11(1):71. (PMID: 31399126)
      Cell Rep. 2017 Oct 10;21(2):366-380. (PMID: 29020624)
      Nat Genet. 2019 Mar;51(3):404-413. (PMID: 30617256)
      Brief Bioinform. 2021 Jul 20;22(4):. (PMID: 33200787)
      Lancet Neurol. 2016 Jul;15(8):857-868. (PMID: 27302364)
      Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655. (PMID: 29145629)
      Cell Rep. 2022 May 3;39(5):110776. (PMID: 35508140)
      Nat Genet. 2007 Jan;39(1):17-23. (PMID: 17192785)
      Hum Mol Genet. 2020 Oct 10;29(17):2899-2919. (PMID: 32803238)
      Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712. (PMID: 21852788)
      F1000Res. 2021 Sep 28;10:979. (PMID: 35814628)
      Nucleic Acids Res. 2000 Jan 1;28(1):27-30. (PMID: 10592173)
      Genome Biol. 2020 Feb 7;21(1):31. (PMID: 32033589)
      Alzheimers Dement. 2024 May;20(5):3587-3605. (PMID: 38534018)
      Cell. 2023 Sep 28;186(20):4404-4421.e20. (PMID: 37774679)
      Alzheimers Dement. 2023 Apr;19(4):1598-1695. (PMID: 36918389)
      BMC Genomics. 2014;15 Suppl 12:S11. (PMID: 25563301)
      Mol Syst Biol. 2021 Jan;17(1):e9620. (PMID: 33491336)
      Mol Syst Biol. 2019 Jun 19;15(6):e8746. (PMID: 31217225)
      Nat Protoc. 2020 Apr;15(4):1484-1506. (PMID: 32103204)
      Nat Methods. 2020 Feb;17(2):147-154. (PMID: 31907445)
      Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25800-25809. (PMID: 32989152)
      Cell. 2023 Sep 28;186(20):4422-4437.e21. (PMID: 37774680)
      J Geriatr Psychiatry Neurol. 2010 Dec;23(4):213-27. (PMID: 21045163)
      Nat Methods. 2023 Aug;20(8):1222-1231. (PMID: 37386189)
      Nucleic Acids Res. 2020 Jun 4;48(10):e55. (PMID: 32196115)
      Science. 2019 Nov 29;366(6469):1134-1139. (PMID: 31727856)
    • Grant Information:
      1RF1AG071683 National Institutes on Aging; U54 AG054349 United States AG NIA NIH HHS; R01 NS128523 United States NS NINDS NIH HHS; R01NS128523 National Institute of Health; U54 AG054349-06 National Institutes on Aging; T32 GM136624 United States GM NIGMS NIH HHS; Adelson Medical Research Foundation funds; RF1 AG071683 United States AG NIA NIH HHS; 1T32GM136624-01 National Institute of Health (NIH) Institutional National Research Service Award
    • Contributed Indexing:
      Keywords: Alzheimer's disease; epigenomics; genetics; multi‐omics; single‐nucleus RNA‐seq; spatial; spatial transcriptomics; transcriptomics
    • Publication Date:
      Date Created: 20240327 Date Completed: 20240515 Latest Revision: 20240716
    • Publication Date:
      20240717
    • Accession Number:
      PMC11095483
    • Accession Number:
      10.1002/alz.13790
    • Accession Number:
      38534018